• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

LACTULOSE Drug Record

  • Summary
  • Interactions
  • Claims
  • LACTULOSE chembl:CHEMBL296306 Approved

    Alternate Names:

    LACTULOSE JP17
    LAXOSE ORANGE
    LEMLAX
    OSMOLAX
    CONSTILAC
    CHOLAC
    LACTULOSE
    CONSTULOSE
    E966
    DUPHALAC DRY
    LAXILOSE
    BIFITERAL
    DUPHALAC
    HEPTALAC
    ACILAC
    EVALOSE
    ENULOSE
    CEPHULAC
    GENERLAC
    CHRONULAC
    PORTALAC
    REGULOSE
    (2S,3R,4S,5R,6R)-2-[[(2R,3S,4S,5S)-4,5-DIHYDROXY-2,5-BIS(HYDROXYMETHYL)-3-TETRAHYDROFURANYL]OXY]-6-(HYDROXYMETHYL)TETRAHYDROPYRAN-3,4,5-TRIOL
    D-LACTULOSE
    CEPHULAC SYRUP
    4-O-BETA-D-GALACTOPYRANOSYL-D-FRUCTOSE
    4-O-BETA-DELTA-GALACTOPYRANOSYL-DELTA-FRUCTOFURANOSE
    4-O-B-D-GALACTOPYRANOSYL-D-FRUCTOSE
    (2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5S)-4,5-DIHYDROXY-2,5-BIS(HYDROXYMETHYL)TETRAHYDROFURAN-3-YL]OXY-6-(HYDROXYMETHYL)TETRAHYDROPYRAN-3,4,5-TRIOL
    (2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-DIHYDROXY-2,5-BIS(HYDROXYMETHYL)OXOLAN-3-YL]OXY-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL
    LACTULOSA
    LACTULOSUM
    4-O-BETA-D-GALACTOPYRANOSYL-D-FRUCTOFURANOSE
    4-O-BETA-DELTA-GALACTOPYRANOSYL-DELTA-FRUCTOSE
    (2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5S)-4,5-DIHYDROXY-2,5-DIMETHYLOL-TETRAHYDROFURAN-3-YL]OXY-6-METHYLOL-TETRAHYDROPYRAN-3,4,5-TRIOL
    4-O-B-D-GALACTOPYRANOSYL-D-FRUCTOFURANOSE
    (2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5S)-4,5-DIHYDROXY-2,5-BIS(HYDROXYMETHYL)OXOLAN-3-YL]OXY-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL
    DELTA-LACTULOSE
    (2S,3R,4S,5R,6R)-2-{[(2R,3S,4S,5R)-4,5-DIHYDROXY-2,5-BIS(HYDROXYMETHYL)OXOLAN-3-YL]OXY}-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL
    drugbank:00581
    rxcui:6218
    pubchem.compound:11333
    chembl:CHEMBL296306
    chemidplus:4618-18-2

    Drug Info:

    (0 More Sources)

    Publications:

    Melichar et al., 2001, Intestinal permeability in patients with chemotherapy-induced stomatitis., J. Cancer Res. Clin. Oncol.
    Peng et al., 2001, Effects of early enteral feeding on the prevention of enterogenic infection in severely burned patients., Burns
    Vendemiale et al., 1992, Crystalline lactulose in the therapy of hepatic cirrhosis. Evaluation of clinical and immunological parameters. Preliminary results., Arzneimittelforschung
  • LACTULOSE   FCGR3B

    Interaction Score: 1.63

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    1418064


    Sources:
    NCI

  • LACTULOSE   FCGR3A

    Interaction Score: 1.29

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    1418064


    Sources:
    NCI

  • LACTULOSE   CSF2

    Interaction Score: 0.75

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    11355146


    Sources:
    NCI

  • LACTULOSE   TNF

    Interaction Score: 0.45

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    11226652


    Sources:
    NCI

  • NCI: LACTULOSE

    • Version: 14-September-2017

    Alternate Names:
    C29148 NCI drug code

    Drug Info:

    Publications:
    Melichar et al., 2001, Intestinal permeability in patients with chemotherapy-induced stomatitis., J. Cancer Res. Clin. Oncol.
    Vendemiale et al., 1992, Crystalline lactulose in the therapy of hepatic cirrhosis. Evaluation of clinical and immunological parameters. Preliminary results., Arzneimittelforschung
    Peng et al., 2001, Effects of early enteral feeding on the prevention of enterogenic infection in severely burned patients., Burns

  • ChemblDrugs: chembl:CHEMBL296306

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21